Submitted by Anonymous (not verified) on 24 October 2024 - 14:51
Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026 to 12 March 2026
Source:
Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026 to 12 March 2026